Position in LEGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,533,954
+$6,524,251 QoQ
Shares Held
260,871
+742.5% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
3.22%
of 13F equity value
Holder Rank
#41
of 218 holders
Holding Since
Sep 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LEGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Resolute Capital Asset Partners LLC holds $62,675,846 across 8 Biotechnology names. LEGN ranks #3 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
118,627 | $31,640,193 | |
| 2 | ARGX |
Argenx SE
|
12,000 | $11,133,240 | |
| 3 | LEGN |
Legend Biotech Corp
This page
|
260,871 | $7,533,954 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
30,000 | $3,512,100 | |
| 5 | CELC |
Celcuity Inc.
|
30,000 | $3,138,600 | |
| 6 | ABVX |
Abivax S.A.
|
17,500 | $2,332,050 | |
| 7 | KOD |
Kodiak Sciences Inc.
|
51,385 | $2,001,959 | |
| 8 | REPL |
Replimune Group, Inc.
|
125,000 | $1,383,750 |
All Filings in LEGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,533,954 | 260,871 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $1,009,703 | 30,963 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,808,676 | 50,963 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,035,800 | 60,000 | Shares | Sole | 2025-05-14 | |
| 2024-09-30 | $2,923,800 | 60,000 | Shares | Sole | 2024-11-08 | |
| No filing history on record for this holder in this stock. | ||||||